Regulation of age-related macular degeneration-like pathology by complement factor H.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4466717)

Published in Proc Natl Acad Sci U S A on May 19, 2015

Authors

Christopher B Toomey1, Una Kelly2, Daniel R Saban3, Catherine Bowes Rickman4

Author Affiliations

1: Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710; Department of Cell Biology, Duke University, Durham, NC 27710;
2: Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710;
3: Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710; Department of Immunology, Duke University, Durham, NC 27710.
4: Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710; Department of Cell Biology, Duke University, Durham, NC 27710; bowes007@duke.edu.

Articles cited by this

Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44

Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 10.88

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33

Age-related macular degeneration. N Engl J Med (2008) 7.49

Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47

Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol (1976) 5.73

A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18

The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08

Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 4.46

Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38

Role of C5a in inflammatory responses. Annu Rev Immunol (2005) 4.38

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet (2002) 4.22

Innate and acquired immunity in atherogenesis. Nat Med (2002) 4.22

The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 4.11

Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med (2008) 3.92

The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39

Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33

The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat Immunol (2011) 3.19

Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64

A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res (2000) 2.58

The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci (2012) 2.53

Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell (2013) 2.49

Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40

Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet (2009) 2.40

NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res (2011) 2.38

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32

Histopathology of age-related macular degeneration. Mol Vis (1999) 2.27

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A (2002) 2.20

Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc (2014) 2.03

Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02

Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol (1999) 2.01

Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99

Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A (2005) 1.92

The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci (2009) 1.84

Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res (2009) 1.80

His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79

Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78

SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci (2007) 1.77

The dynamic nature of Bruch's membrane. Prog Retin Eye Res (2009) 1.71

Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol (2001) 1.64

The oil spill in ageing Bruch membrane. Br J Ophthalmol (2011) 1.62

Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56

Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55

Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis (2006) 1.47

Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res (2007) 1.45

Electroretinography: Some basic principles. Invest Ophthalmol (1970) 1.42

CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med (2013) 1.42

Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39

Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol (2009) 1.37

Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Invest Ophthalmol Vis Sci (2003) 1.36

Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 1.36

Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci (2010) 1.26

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation (2010) 1.18

Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem (2008) 1.18

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17

Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3. Ann N Y Acad Sci (1983) 1.17

Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci (2008) 1.16

Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A (2012) 1.16

Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. Ophthalmology (2002) 1.16

Functions of C5a receptors. J Mol Med (Berl) (2009) 1.10

Phosducin regulates transmission at the photoreceptor-to-ON-bipolar cell synapse. J Neurosci (2010) 1.09

Animals as models of age-related macular degeneration: an imperfect measure of the truth. Vet Pathol (2010) 1.08

The simple design of complement factor H: Looks can be deceiving. Mol Immunol (2006) 1.07

Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol (2001) 1.06

Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol (2013) 1.06

Immunological responses to oxidized LDL. Free Radic Biol Med (2000) 1.04

CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits. Aging (Albany NY) (2010) 1.04

Sulfated proteoglycans in Bruch's membrane of the human eye: localization and characterization using cupromeronic blue. Exp Eye Res (1990) 1.03

Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration. PLoS One (2012) 1.01

Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J (2011) 1.00

The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol (2000) 0.99

Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.98

The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H? J Innate Immun (2013) 0.96

Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm. Proc Natl Acad Sci U S A (2012) 0.96

Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathology. Proc Natl Acad Sci U S A (2013) 0.94

Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol (2006) 0.92

Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. J Immunol (2014) 0.91

Complement component C3 plays a critical role in protecting the aging retina in a murine model of age-related macular degeneration. Am J Pathol (2013) 0.91

Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration. J Immunol (2010) 0.89

Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2012) 0.88

Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.87

Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice. Am J Pathol (2014) 0.85

T-body formation precedes virus-like particle maturation in S. cerevisiae. RNA Biol (2011) 0.85

MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 0.85

The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2014) 0.83

Activated monocytes induce human retinal pigment epithelial cell apoptosis through caspase-3 activation. Lab Invest (2003) 0.81

[Biochemical and histochemical analysis of age related lipid deposits in Bruch's membrane]. Ophthalmologe (1994) 0.81

Human RPE cell apoptosis induced by activated monocytes is mediated by caspase-3 activation. Trans Am Ophthalmol Soc (2003) 0.80